-
Purpose(Empty Backbone)
-
Depositing Lab
-
Publication
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 43828 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRE107 (modified from pGP704)
-
Backbone manufacturerAddgene plasmid 43829
- Backbone size (bp) 5173
-
Modifications to backboneFrom pGP704: SacB1 from pUC58-sacB1 cloned into the EcoRI site. BamHI site in oriV converted to a ClaI site by partial digestion and Klenow treatment. From pRE107: Ampicillin resistance replaced with Chloramphenicol resistance (from pACYC184) by blunted-BamHI digestion.
-
Vector typeBacterial Expression ; Bacterial allelic exchange vector with sacB1
-
Selectable markersSacB (sucrose sensitivity)
Growth in Bacteria
-
Bacterial Resistance(s)Chloramphenicol, 25 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)SM10 λpir
-
Growth instructionsContains lambda pir-dependent R6K replication origin; requires lambda pir-containing bacteria strain
-
Copy numberLow Copy
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer CAT-F (Common Sequencing Primers)
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made bySM10 λpir bacterial strain and pGP704 plasmid backbone from John Mekalanos, Harvard Medical School, Boston, MA. SacB1 gene from plasmid pUC58-sacBI from Dennis Ohman, VCU Medical Center, Richmond, VA. CmR gene from pACYC184 (standard cloning vector - commercially available)
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
The plasmids deposited here comprise a set of SacB1-dependent allelic exchange vectors improved from a previously described suicide vector, pGP704 (Miller and Mekalanos, 1988), by including a system to select for plasmid loss by recombination.
Plasmid pRE107 (Addgene plasmid #43829) was constructed by cloning the appropriate EcoRI fragment from pUC58-sacB1 (McIver et al., 1995) into pGP704 (see associated schematic image). The sacB1 allele is a modified variation of sacB, where unique restriction sites were removed by site directed mutagenesis (McIver et al., 1995). Additionally, the BamHI site in the R6K ori of the resulting plasmid was removed by partial BamHI digestion, blunting the resulting overhangs with PolIk (resulting in the formation of a ClaI site) and screening for its loss by restriction analysis.
To use this plasmid with bla fusions and increase the functionality of this system, the depositing laboratory replaced the ApR gene as follows.
The ApR gene flanked by the remaining BamHI sites was removed and replaced with either CmR, TcR or KmR resistance markers (see associated schematic image).
The CmR gene was PCR-amplified from pACYC184 using two primers
5′-CATGGTACCCGGGCCCTAAATACCTGTGACGGAAGAT-3′
and
5′-AACTGCAGACCCGGGCCCTATCACTTATTCAGGCGTAGC-3′
and standard conditions to produce a 958-bp fragment with overlapping SmaI/ApaI sites. This fragment was cloned into the blunted BamHI sites to produce plasmid pRE112.
The resulting plasmid together with others in this deposited series contain the conditional R6K ori, the origin of transfer (oriT) which allows conjugative transfer from permissive hosts, the sacB1 gene to provide negative selection and a MCS, along with a range of different AbR markers.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pRE112 was a gift from Dieter Schifferli (Addgene plasmid # 43828 ; http://n2t.net/addgene:43828 ; RRID:Addgene_43828) -
For your References section:
Improved allelic exchange vectors and their use to analyze 987P fimbria gene expression. Edwards RA, Keller LH, Schifferli DM. Gene. 1998 Jan 30;207(2):149-57. 10.1016/S0378-1119(97)00619-7 PubMed 9511756